Arvinas (ARVN) Accounts Payables (2017 - 2026)
Arvinas' (ARVN) quarterly Accounts Payables came in at $62.3 million in Q1 2026, down 12.38% year-on-year from $71.1 million in Q1 2025, and down 10.36% quarter-over-quarter from $69.5 million in Q4 2025.
Arvinas (ARVN) Accounts Payables (2017 - 2026) Analysis & Trends
Arvinas' Accounts Payables history runs 10 years deep, the most recent figure standing at $62.3 million for Q1 2026.
- On a quarterly basis, Accounts Payables fell 12.38% year-over-year to $62.3 million in Q1 2026; TTM through Mar 2026 was $62.3 million, a 12.38% decrease from a year earlier, with the FY2025 full-year figure at $69.5 million, down 3.2% from the prior year.
- Accounts Payables slipped to $62.3 million in Q1 2026 per ARVN's latest filing, from $69.5 million in the prior quarter.
- Across five years, Accounts Payables topped out at $92.2 million in Q4 2023 and bottomed at $8.6 million in Q1 2022.
- The 5-year median for Accounts Payables is $71.1 million (2025), against an average of $65.5 million.
- Across the five-year window, Accounts Payables soared 963.87% in 2022 and tumbled 32.01% in 2025, its largest moves.
- Year by year, Accounts Payables stood at $74.7 million in 2022, then increased by 23.43% to $92.2 million in 2023, then decreased by 22.13% to $71.8 million in 2024, then fell by 3.2% to $69.5 million in 2025, then fell by 10.36% to $62.3 million in 2026.
- Per Business Quant, the three latest ARVN Accounts Payables figures stand at $62.3 million (Q1 2026), $69.5 million (Q4 2025), and $55.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | 62.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.30 Mn |
| Dec 31, 2025 | 69.50 Mn |
| Sep 30, 2025 | 55.50 Mn |
| Jun 30, 2025 | 53.10 Mn |
| Mar 31, 2025 | 71.10 Mn |
| Dec 31, 2024 | 71.80 Mn |
| Sep 30, 2024 | 75.90 Mn |
| Jun 30, 2024 | 78.10 Mn |
| Mar 31, 2024 | 76.40 Mn |
| Dec 31, 2023 | 92.20 Mn |
| Sep 30, 2023 | 91.00 Mn |
| Jun 30, 2023 | 74.80 Mn |
| Mar 31, 2023 | 66.00 Mn |
| Dec 31, 2022 | 74.70 Mn |
| Sep 30, 2022 | 49.70 Mn |
| Jun 30, 2022 | 42.10 Mn |
| Mar 31, 2022 | 8.60 Mn |
| Dec 31, 2021 | 54.40 Mn |
| Sep 30, 2021 | 4.67 Mn |
| Jun 30, 2021 | 4.98 Mn |